Life After... gastrointestinal stromal tumour: Battle with cancer helps entrepreneur get to the gist of life
Marcus Chiang was diagnosed with a rare gastrointestinal stromal tumour (GIST) in 2019 and underwent multiple surgeries and medication to manage his condition. Despite personal challenges, Chiang focused on his health, rebuilt his life with support, and now runs two busin…
Intelligence analysis by Llama
Marcus Chiang, a Singaporean entrepreneur, was diagnosed with a rare gastrointestinal stromal tumour (GIST) in 2019. He underwent multiple surgeries and medication to manage his condition and has since rebuilt his life with support, focusing on his health and running two businesses with his wife.
Imagine your body has a special kind of cancer called GIST. It's like a tiny monster growing inside you, and if you don't catch it early, it can be very bad. But if you do catch it early, you can get treatment and feel better. Marcus Chiang had this kind of cancer, and he had to go through a lot to get better. He learned to take care of himself and even started new businesses with his wife. He's a strong person who didn't give up!
Analysis
GIST: A Rare and Aggressive Cancer Type
GIST is a rare type of sarcoma that starts in the stomach or intestine. It is caused by genetic mutations, which result in cells multiplying and forming tumours. GIST is a life-threatening cancer, but the chances of survival are high if the tumour is detected early. According to Nagavalli Somasundaram, who heads the lymphoma and sarcoma department at NCCS' medical oncology division, GIST makes up just 1 per cent of cancers that arise in the digestive tract.
Chiang's Journey: From Diagnosis to Recovery
Marcus Chiang was diagnosed with GIST in 2019, just six months after he got married. He underwent surgery to remove the tumour from his small intestine and was referred to the National Cancer Centre Singapore (NCCS) for further treatment. Chiang received mental and other support from psychologists and medical social workers at NCCS, and continued with plans to further his education, graduating with a master's degree in smart cities design from the Strate School of Design Singapore in January 2022.
The Importance of Early Detection
GIST is a rare cancer, affecting about one in every 100,000 people. Early detection is crucial for survival, as symptoms such as bloating, giddiness, fatigue, or blood in the stool may arise as the tumour progresses. Chiang's case was an outlier, as the tumours occur predominantly in those in their 60s or older. The reasons for such cancers manifesting in younger adults are still unclear.
Rebuilding Life After Cancer
Despite personal challenges, Chiang focused on his health, rebuilt his life with support, and now runs two businesses with his wife while continuing treatment and monitoring. His brush with cancer spurred him to focus more on his health, and he began paying attention to his diet and exercise, reading and listening to podcasts to learn more about how to improve his health and fitness.
Key points
- Marcus Chiang was diagnosed with a rare gastrointestinal stromal tumour (GIST) in 2019.
- He underwent multiple surgeries and medication to manage his condition.
- Chiang focused on his health, rebuilt his life with support, and now runs two businesses with his wife while continuing treatment and monitoring.
- GIST is a rare cancer, affecting about one in every 100,000 people.
- Early detection is crucial for survival, as symptoms such as bloating, giddiness, fatigue, or blood in the stool may arise as the tumour progresses.
Marcus Chiang's story shows that with the right mindset and support, individuals can overcome even the most challenging health issues. His determination to rebuild his life and focus on his health is an inspiration to others facing similar challenges.
The reality of GIST is that it can be a life-threatening cancer if not detected early. The risk of recurrence is high, and patients may need to undergo multiple surgeries and medication to manage their condition. Chiang's experience highlights the importance of ongoing treatment and monitoring to manage the risk of relapse.
